{"result": "{\n    \"title\": \"ROSE Trial and Related Clinical Research\",\n    \"summary\": \"The community is centered around the ROSE trial, a significant clinical study conducted by the PETAL Clinical Trials Network and funded by the National Heart, Lung, and Blood Institute. It explores the efficacy and safety of early neuromuscular blockade in ARDS patients, using cisatracurium as the neuromuscular blocking agent. The trial is closely related to the ACURASYS trial and has been documented in the New England Journal of Medicine, highlighting its importance in the medical research community.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the ROSE trial's potential influence on clinical practices for ARDS treatment.\",\n    \"findings\": [\n        {\n            \"summary\": \"ROSE Trial's focus on ARDS treatment\",\n            \"explanation\": \"The ROSE trial is a pivotal study investigating the efficacy and safety of early neuromuscular blockade in patients with Acute Respiratory Distress Syndrome (ARDS). This trial is crucial as it addresses a significant medical condition that affects many patients worldwide, potentially influencing future treatment protocols. The trial's design and outcomes are expected to provide valuable insights into the management of ARDS, making it a key focus in the medical research community [Data: Entities (190); Relationships (386)].\"\n        },\n        {\n            \"summary\": \"Role of the PETAL Clinical Trials Network\",\n            \"explanation\": \"The PETAL Clinical Trials Network, part of the National Heart, Lung, and Blood Institute, is responsible for conducting the ROSE trial. This network plays a vital role in advancing research on acute lung injury and related conditions. By overseeing the ROSE trial, the PETAL network contributes to the development of evidence-based practices in critical care medicine, emphasizing its importance in the research community [Data: Entities (192); Relationships (622)].\"\n        },\n        {\n            \"summary\": \"Funding and support from the National Heart, Lung, and Blood Institute\",\n            \"explanation\": \"The National Heart, Lung, and Blood Institute (NHLBI) funded the ROSE trial, underscoring the trial's significance and the institute's commitment to advancing research in respiratory and critical care medicine. NHLBI's support highlights the trial's potential impact on public health and its alignment with the institute's mission to improve the understanding and treatment of heart, lung, and blood diseases [Data: Relationships (613)].\"\n        },\n        {\n            \"summary\": \"Connection to the ACURASYS trial\",\n            \"explanation\": \"The ROSE trial was designed to be consistent with certain elements of the ACURASYS trial, which also investigated early neuromuscular blockade in ARDS patients. This connection suggests that the ROSE trial builds upon previous research findings, aiming to validate or refine earlier conclusions. The relationship between these trials highlights the iterative nature of clinical research and the importance of building on established knowledge to advance medical science [Data: Entities (191); Relationships (621)].\"\n        },\n        {\n            \"summary\": \"Publication in the New England Journal of Medicine\",\n            \"explanation\": \"The New England Journal of Medicine (NEJM) published the protocol and statistical analysis plan of the ROSE trial, providing comprehensive access to critical research information. NEJM's involvement underscores the trial's significance, as the journal is a prestigious platform for disseminating important medical studies. This publication ensures that the trial's findings are accessible to the global medical community, facilitating the translation of research into practice [Data: Entities (10); Relationships (42)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n190,ROSE TRIAL,\"The Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) trial is a multicenter, unblinded, randomized trial conducted by the PETAL Clinical Trials Network to assess the efficacy and safety of early neuromuscular blockade in ARDS patients\",5\n10,NEJM,\"The New England Journal of Medicine (NEJM) is a prestigious medical journal known for publishing significant medical studies. The full text of articles, including the study in question, is available on their website, NEJM.org. Additionally, the journal is a platform where important documents such as the protocol and statistical analysis plan for studies are published, ensuring comprehensive access to critical research information.\",3\n191,ACURASYS TRIAL,\"The ACURASYS TRIAL, also known as the ARDS et Curarisation Systematique trial, was a large multicenter clinical trial conducted a decade ago. It investigated the effects of early neuromuscular blockade in patients with Acute Respiratory Distress Syndrome (ARDS). The trial specifically utilized the neuromuscular blocking agent cisatracurium, following a particular dosing regimen and duration of treatment.\",3\n192,PETAL CLINICAL TRIALS NETWORK,\"The Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network is part of the National Heart, Lung, and Blood Institute, responsible for conducting the ROSE trial\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n386,ARDS,ROSE TRIAL,The ROSE trial investigated the efficacy and safety of early neuromuscular blockade in patients with ARDS,37\n382,CISATRACURIUM,ROSE TRIAL,Cisatracurium was used as the neuromuscular blocking agent in the ROSE trial,18\n613,\"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE\",ROSE TRIAL,\"The National Heart, Lung, and Blood Institute funded the ROSE trial\",17\n22,ELI LILLY,NEJM,The full text of the study sponsored by Eli Lilly is available on NEJM.org,11\n43,NEJM,PRONE POSITIONING,The study on prone positioning in ARDS patients was published in the New England Journal of Medicine,9\n623,ACURASYS TRIAL,NHLBI,The ACURASYS trial's protocol was overseen by the NHLBI,8\n621,ROSE TRIAL,ACURASYS TRIAL,The ROSE trial was designed to be consistent with certain elements of the ACURASYS trial,8\n42,NEJM,ACURASYS TRIAL,The protocol and statistical analysis plan of the ACURASYS trial were published in NEJM,6\n622,ROSE TRIAL,PETAL CLINICAL TRIALS NETWORK,The PETAL Clinical Trials Network conducted the ROSE trial,6\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}